TARPLIN, DOWNS & YOUNG, LLC

Lobbying for GILEAD SCIENCES, INC. · A Life-Science Company advancing therapies against life-threatening diseases

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $80,000.00 income · posted Jul 20, 2026

Lobbying activity 3

Budget/Appropriations

federal budget issues

Health Issues

Lobbying related to pharmaceutical policy

Medicare/Medicaid

Lobbying related to pharmaceutical policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.